DNA Vector Formulation

  "E! 1328. Highly Efficient Intravenous Gene Delivery to Solid T umors Using a Novel Polyethylenimine/DNA V ector Tumors Vector Formulation Richard J. Cristiano,1 Hisashi Ishikura,1 Paul Sweeney,2 Motoyuki Yamashita,1 Sandra Wiehle,1 Catherine Papasakelariou,1 Tatianna Robles,1 Colin Dinney.2 1 Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States; 2 Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States.                  

3                

   

  *"   

                          3                     3            

                       

       "        G      -!>/   $*'   

    -#0M,&999/    $*'" %                    0   



    

 3              -!>/%   -$*'/  

  O,;%8     T=         

   

 

         55H  

 

                             

    

         

      #          



           -S/   -C8,55 *"(   D     D  &=  

/               

                

  β 1    "1  !@     !>%$*'"&=  -Bμ $*'/       C8,55 S     

   

 

   

  T69H

    G    

   4*>D   

     "              

3      "    <            !>%$*'"&=              

   -4= &=  

/ 

   ;9H

         

        '  &= 3   

       !>%$*'"&=  

        

  &= 3       "    ,8 3         

     



           



        ->?/           >?     " 3        

  >?   "              

         

 

  3  >?      



                               !>   $*'  % 3   

     %       G                   

1329. Optimization of a Non-V iral V ector for Non-Viral Vector Pulmonary Gene Delivery Tomasz H. Kowalczyk,1 Murali K. Pasumarthy,1 Chris R. Gedeon,1 Osman Muhammad,1 Jennifer M. Payne,1 Susannah L. Hyatt,1 Tamara L. Fink,1 Sharon M. Oette,1 Mark J. Cooper,1 Robert C. Moen.1 1 Copernicus Therapeutics Inc., Cleveland, OH, United States. 0            $*'  

  E             -!>/                   0    

 

              

                                                      !>                $*'      

 $*'                  G   "

    

  

Molecular Therapy Vol. 5, No. 5, May 2002, Part 2 of 2 Parts Copyright © The American Society of Gene Therapy

 "!> E               

         $*'      !    *"       3 8& =9   6&      -A8& A=9   A6&   /   

     

- ?'/    "               

 E  !>          89999 '

 A=9   E

   !> ,999 !> &999   !> ,9999 ' !>  ?'  3 

      $*'   

          

  95H *  

$*' G

                                            -

2%  

/$*' 

 A=9"!>,999 

  3                 

    ;&H   , =;U        

  

        $*' 

 A=9"!>89999

       -L,99 /   -L8& /                    D    -A6&"!> 89999/     

           -A8&"!> 89999/ 

                               !> -A=9"!> ,9999/ 

                     !> -A=9"!> &999/ 

                                                                !>            L8999 @D4%   %μ $*'      C       

  !> ,9999                

              -6   :/

      -        /  

 $*'  

   A=9"!> 89999   A6&"!> 89999  

               $*'  

  A8&"!> 89999     G

                 =9"6&       !>&999"89999

1330. Stabilized PLASmin® Complexes Deliver Exogenous Genes to the Nasal Epithelia of Cystic Fibrosis (CF) Knockout Mice and Confer Partial Physiological Correction of CFTR-Mediated Chloride Transport Assem G. Ziady,1 Christopher Gideon,2 Jennifer M. Payne,2 Ossman Muhammad,2 Sharon Oette,2 Thomas H. Kowalczyk,2 Susanna L. Hyatt,2 Murali K. Pasumarthy,2 Tamara L. Fink,2 J. E. Seng,2 Mark J. Cooper,2 Robert C. Moen,2 Pamela B. Davis.1 1 Pediatrics, Case Western Reserve University, Cleveland, OH, United States; 2Copernics Therapeutics, Inc., Cleveland, OH, United States. !      -!>/"

   "  "D"    $*'        -     $*'/    -!D'( ®  3 /                ,     69 U !     

     

       

       

 899 μ 

  "    3     ,& μ         -L89 B D4%   /     E   3      G        0   3

    !D'( ®  3                     ?     84 " *-?'2!? @/    

   ,& μ                

 899 μ 

 N !D'( ®  3  899 μ

  !D'( ® 3 8&μ(>"@  

N 

 $*'  3   

    "    ,& μ #      

,   

 β"  F" = =;U3

 

  

   

    )   

   N !D'( ®   ( "@  

 N  3  

     β"          3   

                      

  !D'( ®  3        !D'( ®  3          ?      

 899 μ

S435